The magic methyl effect is well acknowledged in medicinal chemistry, but despite its significance, accessing such analogues via derivatization at a late stage remains a pivotal challenge. In an effort to mitigate this major limitation, we here present a strategy for the cobalt-catalysed late-stage C–H methylation of structurally complex drug molecules. Enabling broad applicability, the transformation relies on a boron-based methyl source and takes advantage of inherently present functional groups to guide the C–H activation. The relative reactivity observed for distinct classes of functionalities were determined and the sensitivity of the transformation towards a panel of common functional motifs was tested under various reaction conditions. Without the need for prefunctionalization or postdeprotection, a diverse array of marketed drug molecules and natural products could be methylated in a predictable manner. Subsequent physicochemical and biological testing confirmed the magnitude with which this seemingly minor structural change can affect important drug properties.
This is a preview of subscription content
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Bergman, R. G. Organometallic chemistry: CH activation. Nature 446, 391–393 (2007).
Cernak, T., Dykstra, K. D., Tyagarajan, S., Vachal, R. & Krska, S. W. The medicinal chemist’s toolbox for late stage functionalization of drug-like molecules. Chem. Soc. Rev. 45, 546–576 (2016).
Wencel-Delord, J. & Glorius, F. C–H bond activation enables the rapid construction and late-stage diversification of functional molecules. Nat. Chem. 5, 369–375 (2013).
Larsen, M. A. & Hartwig, J. F. Iridium-catalyzed C–H borylation of heteroarenes: scope, regioselectivity, application to late-stage functionalization, and mechanism. J. Am. Chem. Soc. 136, 4287–4299 (2014).
Berger, F. et al. Site-selective and versatile aromatic C–H functionalization by thianthrenation. Nature 567, 223–228 (2019).
Saint-Denis, T. G., Zhu, R.-Y., Chen, G., Wu, Q.-F. & Yu, J.-Q. Enantioselective C(sp 3)–H bond activation by chiral transition metal catalysts. Science 359, eaao4798 (2018).
Topczewski, J. J., Cabrera, P. J., Saper, N. I. & Sanford, M. S. Palladium-catalysed transannular C–H functionalization of alicyclic amines. Nature 531, 220–224 (2016).
Liao, K. et al. Design of catalysts for site-selective and enantioselective functionalization of non-activated primary C–H bonds. Nat. Chem. 10, 1048–1055 (2018).
Willcox, D. et al. A general catalytic β-C–H carbonylation of aliphatic amines to β-lactams. Science 354, 851–857 (2016).
Hong, S. Y. et al. Selective formation of γ-lactams via C–H amidation enabled by tailored iridium catalysts. Science 359, 1016–1021 (2018).
Barreiro, E. J., Kümmerle, A. E. & Fraga, C. A. M. The methylation effect in medicinal chemistry. Chem. Rev. 111, 5215–5246 (2011).
Schönherr, H. & Cernak, T. Profound methyl effects in drug discovery and a call for new C–H methylation reactions. Angew. Chem. Int. Ed. 52, 12256–12267 (2013).
Li, C., Liang, Y., Evans, R. W., Li, X. & MacMillan, D. W. C. Selective sp 3 C–H alkylation via polarity-match-based cross-coupling. Nature 547, 79–83 (2017).
He, Z.-T., Li, H., Haydl, A. M., Whiteker, G. T. & Hartwig, J. F. Trimethylphosphate as a methylating agent for cross coupling: a slow-release mechanism for the methylation of arylboronic esters. J. Am. Chem. Soc. 140, 17197–17202 (2018).
Daugulis, O., Roane, J. & Tran, L. D. Bidentate, monoanionic auxiliary-directed functionalization of carbon–hydrogen bonds. Acc. Chem. Res. 48, 1053–1064 (2015).
Rouquet, G. & Chatani, N. Catalytic functionalization of C(sp 2)–H and C(sp 3)–H bonds by using bidentate directing groups. Angew. Chem. Int. Ed. 52, 11726–11743 (2013).
Gandeepan, P. et al. 3d transition metals for C–H activation. Chem. Rev. 119, 2192–2452 (2019).
Evano, G. & Theunissen, C. Beyond Friedel and Crafts: directed alkylation of C–H bonds in arenes. Angew. Chem. Int. Ed. 58, 2–37 (2019).
Chen, Z. et al. Transition metal-catalyzed C–H bond functionalizations by the use of diverse directing groups. Org. Chem. Front. 2, 1107–1295 (2015).
Graczyk, K., Haven, T. & Ackermann, L. Iron-catalyzed C(sp 2)–H and C(sp 3)–H methylations of amides and anilides. Chem. Eur. J. 21, 8812–8815 (2015).
Shang, R., Ilies, L. & Nakamura, E. Iron-catalyzed ortho C–H methylation of aromatics bearing a simple carbonyl group with methylaluminum and tridentate phosphine ligand. J. Am. Chem. Soc. 138, 10132–10135 (2016).
Thuy-Boun, P. S. et al. Ligand-accelerated ortho-C–H alkylation of arylcarboxylic acids using alkyl boron reagents. J. Am. Chem. Soc. 135, 17508–17513 (2013).
Neufeldt, S. R., Seigerman, C. K. & Sanford, M. S. Mild palladium-catalyzed C–H alkylation using potassium alkyltrifluoroborates in combination with MnF3. Org. Lett. 15, 2302–2305 (2013).
Rosen, B. R. et al. C–H functionalization logic enables synthesis of (+)-hongoquercin A and related compounds. Angew. Chem. Int. Ed. 52, 7317–7320 (2013).
Yoshino, T. & Matsunaga, S. (Pentamethylcyclopentadienyl)cobalt(iii)-catalyzed C–H bond functionalization: from discovery to unique reactivity and selectivity. Adv. Synth. Catal. 359, 1245–1262 (2017).
Moselage, M., Li, J. & Ackermann, L. Cobalt-catalyzed C–H activation. ACS Catal. 6, 498–525 (2016).
Weissman, S. A. & Anderson, N. G. Design of experiments (DoE) and process optimization. A review of recent publications. Org. Process Res. Dev. 19, 1605–1633 (2015).
Santanilla, A. B. et al. Nanomole-scale high-throughput chemistry for the synthesis of complex molecules. Science 347, 49–53 (2015).
Tu, N. P. et al. High-throughput reaction screening with nanomoles of solid reagents coated on glass beads. Angew. Chem. Int. Ed. 58, 7987–7991 (2019).
Gesmundo, N. J. et al. Nanoscale synthesis and affinity ranking. Nature 557, 228–332 (2018).
Sambiagio, C. et al. A comprehensive overview of directing groups applied in metal-catalysed C–H functionalization chemistry. Chem. Soc. Rev. 47, 6603–6743 (2018).
Tomberg, A. et al. Relative strength of common directing groups in palladium-catalyzed aromatic C–H activation. iScience 20, 373–391 (2019).
Collins, K. D. & Glorius, F. A robustness screen for the rapid assessment of chemical reactions. Nat. Chem. 5, 597–601 (2013).
Kutchukian, P. S. et al. Chemistry informer libraries: a chemoinformatics enabled approach to evaluate and advance synthetic methods. Chem. Sci. 7, 2604–2613 (2016).
Smith, J. M., Dixon, J. A., deGruyter, J. N. & Baran, P. S. Alkyl sulfinates: radical precursors enabling drug discovery. J. Med. Chem. 62, 2256–2264 (2019).
Uehling, M. R., King, R. P., Krska, S. W., Cernak, T. & Buchwald, S. L. Pharmaceutical diversification via palladium oxidative addition complexes. Science 363, 405–408 (2019).
Dai, H.-X., Stepan, A. F., Plummer, M. S., Zhang, Y.-H. & Yu, J.-Q. Divergent C–H functionalizations directed by sulfonamide pharmacophores: late-stage diversification as a tool for drug discovery. J. Am. Chem. Soc. 133, 7222–7228 (2011).
Blakemore, D. C. et al. Organic synthesis provides opportunities to transform drug discovery. Nat. Chem. 10, 383–394 (2018).
Bäurle, S. et al. Identification of a benzimidazolecarboxylic acid derivative (BAY 1316957) as a potent and selective human prostaglandin E2 receptor subtype 4 (hEP4-R) antagonist for the treatment of endometriosis. J. Med. Chem. 62, 2541–2563 (2019).
The authors thank R. Sheppard and M. A. Hayes for valuable insight on biological testing, M. Härslätt and A. Ristinmaa for purification support, and M. A. Hayes and M. Lemurell for advice on the preparation of this manuscript. S.D.F. and M.J.J. acknowledge AstraZeneca and the AstraZeneca PostDoc program for their financial support. L.A. acknowledges the Georg-August-Universität Göttingen.
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Experimental protocols and characterization for compounds mentioned in this work, references supporting Fig. 1b, overview of reaction optimization, description of competition experiments and compatibility screening, de novo synthesis strategies, PhysChem-, DMPK- and pharmacological activity data for selected compound and NMR spectra..
About this article
Cite this article
Friis, S.D., Johansson, M.J. & Ackermann, L. Cobalt-catalysed C–H methylation for late-stage drug diversification. Nat. Chem. 12, 511–519 (2020). https://doi.org/10.1038/s41557-020-0475-7
Nature Reviews Chemistry (2021)
Nature Catalysis (2021)
Nature Reviews Methods Primers (2021)
Programmable late-stage C−H bond functionalization enabled by integration of enzymes with chemocatalysis
Nature Catalysis (2021)
Nature Chemistry (2020)